Download - Glenmark

Schedules annexed to and forming part of the Financial Statements
(All amounts in millions of Indian Rupees, unless otherwise stated)
2010-2011 2009-2010
4. Sale of fixed assets to 15.40 19.15
Glenmark Pharmaceuticals S.A., Switzerland - 0.75
Glenmark Generics Ltd., India 15.40 18.40
5. Purchase of fixed assets - 23.40
Glenmark Pharmaceuticals S.A., Switzerland - 23.40
6. Advances given - 2.40
Glenmark Pharmaceuticals (Nigeria) Ltd., Nigeria - 2.40
7. Loan given to 8,325.38 3,417.08
Glenmark Holding S.A., Switzerland 3,622.63 3,410.34
Glenmark Generics Ltd., India 4,702.75 -
Glenmark Pharmaceuticals Egypt S.A.E., Egypt - 6.74
8. Loan and interest repaid by 2,778.53 1,598.64
Glenmark Holding S.A., Switzerland 2,208.34 997.57
Glenmark Generics Ltd., India 430.48 594.33
Glenmark Pharmaceuticals Egypt S.A.E., Egypt - 6.74
Glenmark Impex L.L.C., Russia 139.71 -
9. Interest on loan given 494.37 684.80
Glenmark Impex L.L.C., Russia 5.37 14.08
Glenmark Holding S.A., Switzerland 299.57 260.73
Glenmark Pharmaceuticals (Nigeria) Ltd., Nigeria 3.10 3.20
Glenmark Generics Ltd., India 186.33 406.55
Glenmark Pharmaceuticals Egypt S.A.E., Egypt - 0.24
10. Expenses paid on behalf of Glenmark Pharmaceuticals Ltd., India 103.36 54.22
Glenmark Farmaceutica Ltda., Brazil - 0.24
Glenmark Generics Ltd., India 3.41 3.44
Glenmark Impex L.L.C., Russia 27.89 24.47
Glenmark Pharmaceuticals FZE., United Arab Emirates 29.75 26.07
Glenmark Pharmaceuticals Malaysia Sdn.Bhd.,Malaysia 42.31 -
11. Expenses paid on behalf of Glenmark Generics Ltd., India 91.23 85.22
12. Reimbursement of expenses to Glenmark Exports Ltd., India 0.60 45.78
13. Other Income from 24.10 30.35
Glenmark Generics Ltd., India 12.89 4.29
Glenmark Holding S.A., Switzerland 11.21 26.06
14. Labour Charges to Glenmark Generics Ltd., India - 0.59
15. Factory rent to Glenmark Generics Ltd., India 1.65 1.65
Key management personnel
Remuneration 54.43 36.07
Mr. Gracias Saldanha 0.06 0.12
Mrs. B. E. Saldanha 0.08 0.06
Mr. Glenn Saldanha 32.25 18.28
Mrs. Cheryl Pinto 12.10 9.41
Mr. A. S. Mohanty 9.94 8.20
e) Related party balances
Receivable/(Payable) from/(to) subsidiary companies/enterprise 15,823.93 9,888.72
Glenmark Exports Ltd., India 149.98 159.48
Glenmark Farmaceutica Ltda., Brazil 19.40 63.63
Glenmark Philippines Inc., Philippines 20.38 18.08
Glenmark Pharmaceuticals S.A., Switzerland 856.09 918.44
Glenmark Holding S.A., Switzerland 8,993.38 7,422.43
Glenmark Pharmaceuticals (Nigeria) Ltd., Nigeria 56.04 47.24
Annual Report 2010-2011 69